Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 01:45 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 30, 2025 09:09 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 27, 2025 10:15 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) DEADLINE ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 20, 2025 08:30 ET | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 16, 2025 16:03 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) INVESTOR ALERT Investors With Large Losses in MoonLake Immunotherapeutics Should Contact Bernstein Liebhard LLP To Discuss Their Rights

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 15, 2025 11:18 ET | Source: Block & Leviton LLP

SHAREHOLDER ALERT: MoonLake Immunotherapeutics Sued For Securities Fraud by Block & Leviton LLP; December 15 Deadline To Seek To Serve As Lead Plaintiff

Block & Leviton filed a class action lawsuit today against MoonLake Immunotherapeutics (Nasdaq: MLTX). Investors should contact the firm by December 15.
October 06, 2025 14:35 ET | Source: Block & Leviton LLP

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation.
September 29, 2025 10:53 ET | Source: Block & Leviton LLP

BREAKING: MoonLake Immunotherapeutics Shares Down Over 85%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Shares of MoonLake Immunotherapeutics are down over 85% today. Block & Leviton is investigating MoonLake's public statements about its drug trials.